Funds & Fund Managers
|Average Manager Total Return : 9.6% (31 July 2016 - 31 July 2017)|
|1 of 6||
|1 of 6||
|3 of 6||
|4 of 6||
|5 of 6||
|6 of 6||
Syncona soars 26% since Battle Against Cancer makeover
Investors who took the plunge in December and backed Battle Against Cancer Investment Trust’s transformation into Syncona, the UK’s largest listed life sciences investor, have been rewarded.
Impax: even Trump can’t stop the march of renewables
Impax Environmental Markets manager Bruce Jenkyn-Jones says even Donald Trump’s policies can’t stop the economics driving renewable energy take-up.
Schroder AsiaPacific cuts management fee
Schroder AsiaPacific manager Matthew Dobbs believes investors are failing to recognise China's stabilising influence on the global economy.
James Carthew: is China’s transformation overlooked?
After a stellar year for Chinese equity investment trusts, investors are wondering whether the party can continue.
ScotGems squeezes to market with minimum £50m flotation
Modest support for Stewart Investors’ new global smaller companies’ trust partly offset by news of legendary US small-cap investor James Findlay joining the board.
‘Strong and stable’ Japan finally breaks deflationary cycle
Sarah Whitley, Baillie Gifford’s top-performing Japan fund manager, points to evidence that ‘Abenomics’ is starting to solve the country's persistent deflation problem.